These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21779670)

  • 1. Infectious keratitis in patients undergoing Boston Type 1 keratoprosthesis (Boston KPro) procedure: case series.
    Nascimento HM; Oliveira LA; Höfling-Lima AL
    Arq Bras Oftalmol; 2011; 74(2):127-9. PubMed ID: 21779670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectious keratitis after Boston type 1 keratoprosthesis implantation.
    Chan CC; Holland EJ
    Cornea; 2012 Oct; 31(10):1128-34. PubMed ID: 22960647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infectious Keratitis After Boston Type 1 Keratoprosthesis Implantation.
    Ghaffari R; Bonnet C; Yung M; Bostan C; Harissi-Dagher M; Aldave AJ
    Cornea; 2021 Oct; 40(10):1298-1308. PubMed ID: 33630813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectious endophthalmitis after Boston type 1 keratoprosthesis implantation.
    Chan CC; Holland EJ
    Cornea; 2012 Apr; 31(4):346-9. PubMed ID: 22314825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fungal colonization and infection in Boston keratoprosthesis.
    Barnes SD; Dohlman CH; Durand ML
    Cornea; 2007 Jan; 26(1):9-15. PubMed ID: 17198007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial Keratitis and Endophthalmitis After the Boston Type 1 Keratoprosthesis.
    Wagoner MD; Welder JD; Goins KM; Greiner MA
    Cornea; 2016 Apr; 35(4):486-93. PubMed ID: 26764885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial keratitis after Boston type I keratoprosthesis implantation: incidence, organisms, risk factors, and outcomes.
    Kim MJ; Yu F; Aldave AJ
    Ophthalmology; 2013 Nov; 120(11):2209-16. PubMed ID: 23747162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contact lens surveillance cultures in Boston type 1 keratoprosthesis patients.
    Rai R; Shorter E; Cortina MS; McMahon T; de la Cruz J
    Eye Contact Lens; 2013 Mar; 39(2):175-8. PubMed ID: 23392305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infections after keratoprosthesis.
    Davies E; Chodosh J
    Curr Opin Ophthalmol; 2016 Jul; 27(4):373-7. PubMed ID: 27138637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trichosporon asahii keratitis in a patient with a type I Boston keratoprosthesis and contact lens.
    Keating A; Pineda R
    Eye Contact Lens; 2012 Mar; 38(2):130-2. PubMed ID: 21876439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endophthalmitis in Eyes With the Boston Type I Keratoprosthesis: Incidence, Recurrence, Risk Factors, and Outcomes.
    Bostan C; Nayman T; Szigiato AA; Morfeq H; Harissi-Dagher M
    Cornea; 2021 Oct; 40(10):1258-1266. PubMed ID: 33394754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
    Sejpal K; Yu F; Aldave AJ
    Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and prognosis of Boston type I keratoprosthesis-associated corneal melt.
    Utine CA; Tzu JH; Akpek EK
    Ocul Immunol Inflamm; 2011 Dec; 19(6):413-8. PubMed ID: 22106908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiota evaluation of patients with a Boston type I keratoprosthesis treated with topical 0.5% moxifloxacin and 5% povidone-iodine.
    Magalhães FP; do Nascimento HM; Ecker DJ; Sannes-Lowery KA; Sampath R; Rosenblatt MI; de Sousa LB; de Oliveira LA
    Cornea; 2013 Apr; 32(4):407-11. PubMed ID: 22488148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Aurolab Keratoprosthesis (KPro) versus the Boston Type I Kpro: 5-year Clinical Outcomes in 134 Cases of Bilateral Corneal Blindness.
    Basu S; Serna-Ojeda JC; Senthil S; Pappuru RR; Bagga B; Sangwan V
    Am J Ophthalmol; 2019 Sep; 205():175-183. PubMed ID: 30905723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mid- and Longterm Experiences with the Boston-Keratoprosthesis. The Cologne and Salzburg Perspective].
    Schaub F; Bachmann BO; Seyeddain O; Moussa S; Reitsamer HA; Cursiefen C
    Klin Monbl Augenheilkd; 2017 Jun; 234(6):770-775. PubMed ID: 28586930
    [No Abstract]   [Full Text] [Related]  

  • 17. Fungal keratitis with the type 1 Boston keratoprosthesis: early Indian experience.
    Jain V; Mhatre K; Shome D; Pineda R
    Cornea; 2012 Jul; 31(7):841-3. PubMed ID: 22531432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers.
    Robert MC; Biernacki K; Harissi-Dagher M
    Cornea; 2012 Apr; 31(4):339-45. PubMed ID: 22269678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
    Fadlallah A; Atallah M; Cherfan G; Awwad ST; Syed ZA; Melki SA
    Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of Fungal Keratitis in Boston Type I Keratoprosthesis: Importance of Awareness and Novel Identification of Exophiala phaeomuriformis.
    Machen L; Chau FY; de la Cruz J; Sugar J; Cortina MS
    Cornea; 2018 May; 37(5):655-657. PubMed ID: 29474297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.